FDA Approves Pathway for Personalized Gene Editing Medicines
The Dawn of Bespoke Medicine: How Individualized Treatments Are Reshaping Healthcare The Food and Drug Administration (FDA) recently released guidance paving the way for the approval of the first truly personalized medicines, designed to address a patient’s unique genetic makeup. This shift, spearheaded by FDA Commissioner Marty Makary and biologics chief Vinay Prasad, marks a … Read more